137 related articles for article (PubMed ID: 9398978)
1. Prognostic factors in oligodendroglioma.
Schiffer D; Dutto A; Cavalla P; Bosone I; Chiò A; Villani R; Bellotti C
Can J Neurol Sci; 1997 Nov; 24(4):313-9. PubMed ID: 9398978
[TBL] [Abstract][Full Text] [Related]
2. Role of apoptosis in the prognosis of oligodendrogliomas.
Schiffer D; Dutto A; Cavalla P; Chiò A; Migheli A; Piva R
Neurochem Int; 1997 Aug; 31(2):245-50. PubMed ID: 9220457
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas.
Vaquero J; Zurita M; Coca S; Oya S; Morales C
Surg Neurol; 2000 Sep; 54(3):229-34; discussion 234. PubMed ID: 11118569
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.
Dehghani F; Schachenmayr W; Laun A; Korf HW
Acta Neuropathol; 1998 May; 95(5):493-504. PubMed ID: 9600596
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
[TBL] [Abstract][Full Text] [Related]
7. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
8. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
Kamiya M; Nakazato Y
Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.
Coons SW; Johnson PC; Pearl DK
Neurosurgery; 1997 Oct; 41(4):878-84; discussion 884-5. PubMed ID: 9316050
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
Korshunov A; Golanov A; Sycheva R
J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of vessel productive changes and vessel density in oligodendroglioma.
Schiffer D; Bosone I; Dutto A; Di Vito N; Chiò A
J Neurooncol; 1999 Sep; 44(2):99-107. PubMed ID: 10619493
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas.
Maiuri F; Del Basso De Caro ML; Iaconetta G; Peca C; Esposito M; de Divitiis E
Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors in Oligodendrogliomas: a Clinical Study of Twenty-Five Consecutive Patients.
Atalay T; Ak H; Celik B; Gulsen I; Seckin H; Tanik N; Albayrak SB; Bavbek M
Asian Pac J Cancer Prev; 2015; 16(13):5319-23. PubMed ID: 26225672
[TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis.
Heegaard S; Sommer HM; Broholm H; Broendstrup O
Cancer; 1995 Nov; 76(10):1809-13. PubMed ID: 8625052
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 in oligodendroglial neoplasms.
Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
[TBL] [Abstract][Full Text] [Related]
16. Classification of oligodendroglial tumors based on histopathology criteria is a significant predictor of survival--clinical, radiological and pathologic long-term follow-up analysis.
Sepulveda Sanchez JM; Martinez Montero JC; Diez-Lobato R; Hernandez-Lain A; Cabello A; Ramos A; Gonzalez Leon P; Ricoy Campo JR
Clin Neuropathol; 2009; 28(1):11-20. PubMed ID: 19216215
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of malignant features in oligodendroglial tumors.
Saito A; Nakazato Y
Clin Neuropathol; 1999; 18(2):61-73. PubMed ID: 10192700
[TBL] [Abstract][Full Text] [Related]
18. High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas.
Miettinen HE; Järvinen TA; Kellner U; Kauraniemi P; Parwaresch R; Rantala I; Kalimo H; Paljärvi L; Isola J; Haapasalo H
Neuropathol Appl Neurobiol; 2000 Dec; 26(6):504-12. PubMed ID: 11123716
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
Majumdar K; Radotra BD; Vasishta RK; Pathak A
Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
[TBL] [Abstract][Full Text] [Related]
20. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
